Published : 11 Feb 2026
To better deliver value and help clients reach their goals by optimising resources, Aagami has joined forces with a respected company that assists businesses in raising capital efficiently through a hybrid model involving Reg CF platforms.
Our partner is a specialised investment banking and strategic advisory firm dedicated to the life sciences field—including biotechnology, diagnostics, and medical devices. This firm supports emerging and growth-stage companies by offering:
1. Licensing partnership opportunities with major pharmaceutical companies
2. Capital raising via private placements and PIPEs
3. Public listings through Alternative Public Offerings (APOs), such as reverse mergers
4. Strategic advice on uplisting and compliance
The founder of the firm is a FINRA-licensed investment banker who brings over 30 years of experience in life sciences deals.
The team has a solid history of achieving results in private capital raises, licensing arrangements, and public market transactions.
If you are interested in exploring Reg CF options, please email us at action@aagami.com and include “Reg CF” in the subject line.